Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery
Transcript of Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery
![Page 1: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/1.jpg)
MIGS:Minimally Invasive Glaucoma
Surgery
Ilya Rozenbaum, MDMatossian Eye Associates
June 2014
![Page 2: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/2.jpg)
Disclosures
Speaker/Consultant:Allergan
Alcon
![Page 3: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/3.jpg)
Human Cost of Glaucoma•Glaucoma is the second leading cause of blindness worldwide•Global estimates of glaucoma cases exceeded 60M in 2010 and are estimated to grow to 78M by 2020•Bilateral blindness is occurring at an alarming 7.5% of OAG cases globally, growing from 4.4M to 6M patients between 2010 and 2020•In the US, there are an estimated 2.2M cases of OAG, growing to more than 3M cases by 2020, with more than 88,000 of these patients going blind
1.Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 2006 March; 90(3): 262–267.2.Congdon NG, De Jong PT, Klein BE et al.Glaucoma as a cause of blindness in the United States. American Glaucoma Society Annual Meeting 2003; abstract.3.Friedman DS, De Jong PT, Klein BE, et al. Glaucoma prevalence in the United States: results of a meta-analysis. American Glaucoma Society Annual Meeting 2003; Abstract.
![Page 4: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/4.jpg)
Problems with Glaucoma Meds Future surgery success rate may be lower Quality of life Cost Compliance Side effects:
Death from beta-blockers Fatal aplastic anemia (CAIs) Severe allergic reactions Retinal detachment (pilocarpine) Irritation, redness, etc
![Page 5: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/5.jpg)
Glaucoma: Surgical Disease
CIGTS: Glaucomatous optic disc progression
is higher in patients on medical treatment than surgical patients
Five-year Follow-up Optic Disc Findings of the Collaborative Initial Glaucoma Treatment Study. Am J Ophthalmol 2009;147:717–724.
![Page 6: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/6.jpg)
Surgical optionsTrabeculectomy or ExPressTube shunts
Ahmed, Baerveldt, Molteno
Laser trabeculoplastyTrans-scleral laserCanaloplastyMIGS
Glaucoma: Surgical Disease
![Page 7: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/7.jpg)
Trabeculectomy 2014Advantages
Still the gold standard surgery No device needed - available, cost-effective Can achieve low IOPs
Disadvantages Less standardized (hasn’t significantly
changed in 50 years) Complications in up to 40% Failure in up to 50% at 5 years Cataract in 50% at 5 years
Gedde SJ, Schiffman JC, Feuer WJ, et al. Am J Ophthalmol. 2012;153:789-803 e2.
Glaucoma: Surgical Disease
![Page 8: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/8.jpg)
TVT study: complications
Early postoperative complications: 21% (tube) and 37% (trab)
Late postoperative complications (up to 5 years after surgery): 34% (tube) and 36% (trab)
Cataract surgery: 54% of phakic tube eyes and 43% of phakic trab eyes
Reoperation for surgical complications: 22% (tube) and 18% (trab)
Gedde SJ, Herndon LW, Brandt JD, et al. Am J Ophthalmol. 2012;153:804-814 e1.
Glaucoma: Surgical Disease
![Page 9: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/9.jpg)
Bleb LeakEvaluation must be done with high concentration fluoresceinCascading darker/clear fluid with fluorescent edges is a leak
![Page 10: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/10.jpg)
Endophthalmitis
![Page 11: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/11.jpg)
Tube Erosion
![Page 12: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/12.jpg)
Plate Erosion
![Page 13: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/13.jpg)
Ideal glaucoma surgery?
As effective as trabeculectomy but saferReproducible/PredictableNo blebEasy to performLess post-operative effortCost-effective
![Page 14: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/14.jpg)
Mansberger SL, et al. Reduction in intraocular pressure after cataract extraction: the ocular hypertension treatment study. Ophthalmology. 2012 Sep;119:1826-31.
Cataract surgery vs. controls from OHTS:
16.5% reduction in IOP sustained for 36 months
![Page 15: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/15.jpg)
Centers for Medicare and Medicaid Services. 2002 – 2007. Medicare Standard Analytical File. Baltimore, MD. 2007.
Concomitant Cataract & Glaucoma (US)
1 in 5 Cataract Eyes on OHT Medication
![Page 16: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/16.jpg)
SITA-Standard HVF 24-2
![Page 17: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/17.jpg)
MIGS
MinimallyInvasive
GlaucomaSurgery
![Page 18: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/18.jpg)
Minimally Invasive Glaucoma Surgery (MIGS)
Ab interno microincisional approach Minimally traumatic to the target tissue Safe and (at least modest) IOP reduction Rapid recovery with minimal impact on the
patient’s quality of life Typically indicated for mild to moderate POAG
Curr Opin Ophthalmol 2012, 23:96–104
![Page 19: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/19.jpg)
iStent Trabecular Micro-Bypass Stent (Glaucos)
1 mm x 0.33 mm
Snorkel: 0.25 mm x 120 µm (bore diameter)
Weight: 60 µg
Surgical grade nonferromagnetic titanium
Heparin-coated to promote self-priming and facilitate outflow
iStent® is FDA approved in the U.S., C.E. marked in the E.U., and has Medical Device Approval in Canada
Open Half Pipe
Self-Trephining Tip
Snorkel0.3 mm
Retention ArchesLumen 120 µm
![Page 20: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/20.jpg)
iStent
![Page 21: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/21.jpg)
iStent: Indication
In conjunction with
cataract surgery
Mild to moderate open-
angle glaucoma
Currently treated with
ocular hypotensive
medication
iStent® is FDA approved in the U.S., C.E. marked in the E.U., and has Medical Device Approval in Canada
For patients with OAG/OHTN who also need cataract surgery
![Page 22: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/22.jpg)
iStent
Done with cataract surgery
![Page 23: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/23.jpg)
Designed to improve aqueous outflow thru the natural physiologic pathway
Creates a bypass thru trabecular meshwork to Schlemm’s canal
iStent: Mechanism
iStent® is FDA approved in the U.S., C.E. marked in the E.U., and has Medical Device Approval in Canada
![Page 24: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/24.jpg)
iStent
![Page 25: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/25.jpg)
iStent Surgical Video
![Page 26: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/26.jpg)
Ophthalmology. 2011 Mar;118(3):459-67.
At 12 months:68% of iStent subjects with IOP ≤ 21 mm Hg without medication vs. 50% with cataract surgery alone (p=0.004)
0
20
40
60
80
100
Cataract Surgery iStent
Percent of Eyes With IOP ≤ 21 mm Hg Without Medication Use
![Page 27: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/27.jpg)
Ophthalmology. 2011 Mar;118(3):459-67.
At 12 months:
15% of iStent vs.
35% cataract group on
medication (p=0.001)
0
50
100
Cataract Surgery iStent
Percent of Patients on Ocular Hypotensive Medication
![Page 28: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/28.jpg)
Complication iStent + Cataract Surgery N = 111
Cataract Surgery N = 122
Anticipated early postoperative event 14(13%) 15(12%)
Stent obstruction by iris, vitreous, fibrous overgrowth, fibrin, blood, and so forth
4(4%) 0(0%)
Posterior capsular opacification 3(3%) 8(7%)
Stent malposition 3(3%) 0(0%)
Subconjunctival hemorrhage 2(2%) 2(2%)
Elevated IOP, other 2(2%) 1(1%)
Epiretinal membrane 2(2%) 1(1%)
Iris atrophy 2(2%) 0(0%)
Blurry vision or visual disturbance 1(1%) 6(5%)
Iritis 1(1%) 6(5%)
Dry eye 1(1%) 2(2%)
Elevated IOP requiring treatment with oral or intravenous medications or with surgical intervention
1(1%) 2(2%)
Macular edema 1(1%) 2(2%)
Foreign body sensation 0(0%) 3(2%)
Allergic conjunctivitis 0(0%) 2(2%)
Mild pain 0(0%) 2(2%)
Rebound inflammation from tapering steroids 0(0%) 2(2%)
![Page 29: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/29.jpg)
iStentLower IOPFewer medicationsNo bleb!!
![Page 30: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/30.jpg)
What's in the Pipeline?
2 “iStent inject” vs latanoprost/timolol
![Page 31: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/31.jpg)
Endoscopic Cyclo Photocoagulation(ECP) - EndoOptiks
![Page 32: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/32.jpg)
ECP
![Page 33: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/33.jpg)
ECP
ECP is the selective ablation of aqueous producing ciliary processes via an ab interno approach
Inhibits aqueous production, therefore reducing IOP and medication use
ECP has been performed globally for over 12 years
More than 50,000 patients treated to date
![Page 34: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/34.jpg)
ECP Indications
Mild to moderate glaucoma (any type)
or Refractory glaucoma (after multiple failed
glaucoma surgeries)
![Page 35: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/35.jpg)
Phaco-ECP: Phaco-ECP: Combined ECP and Cataract Surgery
Lindfield D, Ritchie RW, Griffith MF. BMJ Open 2012
![Page 36: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/36.jpg)
ECP COLLABORATIVE STUDY GROUPSAFETY STUDY: COMPLICATIONS
IOP Spike 14.5%Hemorrhage 3.8%Serous Choroidal Effusion 0.36%IOL Dislocation 0.36%CME 1.03%RD 0.27%Massive Choroidal Hemorrhage 0.09%Hypotony or Phthisis 0.12%NLP Vision 0.12%Cataract 24.5%Acute Graft Rejection 5.3%Chronic Graft Rejection 0Chronic Inflammation 0Flat AC 0Endophthalmitis 0Diplopia 0Wound Leak 0Bleb Complications 0
5824 PATIENTS
![Page 37: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/37.jpg)
Trabectome (Neomedix)
![Page 38: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/38.jpg)
Ablates and removes a strip of trabecular meshwork and re-establishes access to the eye’s natural drainage pathway
Trabectome
38
![Page 39: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/39.jpg)
Review of 115 Trabectome patients vs. 102 trab-MMC patients.
Success rates (IOP<21 mmHg or >20% reduction) at 2 years:
22.4% for trabectome and 76.1% for trab (P=0.001)
Ophthalmology. 2012 Jan;119(1):36-42.
![Page 40: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/40.jpg)
Trabectome had 100% hyphema POD #1, plus 4.3% other complications, compared to 35.3% complication rate for trabeculectomy (P=.001)
Ophthalmology. 2012 Jan;119(1):36-42.
![Page 41: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/41.jpg)
Side Effects and Complications Descemet’s injury Ciliary body injury Reflux bleeding, hyphema Zonule injury
Trabectome
![Page 42: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/42.jpg)
The ICE Procedure
Cataract Extraction
ECPiStent
![Page 43: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/43.jpg)
What is ICE?
16.5% IOP lowering at 3 yearsMansberger. Ophthal. 2012;
119:1826-31.
33% IOP lowering with
cataract extraction
Samuelson. Ophthal. 2011;118:459-67.
43% IOP lowering with cataract extractionKahook; J Glaucoma. 2007;16:527-30.
![Page 44: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/44.jpg)
Mechanisms of ICE?
? Angle widening? Decreased
aqueous production
Increased trabecular outdlow
Decreased aqueous production
![Page 45: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/45.jpg)
% o
f eye
sPreoperative vs. Month 3-6 IOP Reduction
(n=48)
![Page 46: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/46.jpg)
% o
f eye
sPreoperative vs. Month 3-6 IOP
![Page 47: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/47.jpg)
Projected cost savings at 6 years in $:
What about Cost?
Iordanous Y et al. J Glaucoma. 2014 Feb;23(2):e112-8.
1 drop 2 drops 3 drops
iStent -20.77 1272.55 2124.71
ECP 779.23 2072.55 2924.71
Trabectome 279.23 1572.55 2424.71
![Page 48: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/48.jpg)
Summary
Appreciation for the risks and complications associated with traditional glaucoma surgery has ignited the MIGS revolution
MIGS, combined with cataract surgery, provides safe new options for IOP reduction
Lots of options, data is forthcoming Trabeculectomy and tube shunt surgery for
significant IOP reduction
![Page 49: Spring 2014 - MIGS : Minimally Invasive Glaucoma Surgery](https://reader035.fdocuments.net/reader035/viewer/2022062311/589c38b21a28ab634a8b4fe9/html5/thumbnails/49.jpg)
Thank you!
Hopewell office 609-882-8833
Doylestown office 215-230-9200
Cell 646-263-3045